ClinicalTrials.Veeva

Menu

Cycloplegia and Refractive Status

A

Al-Azhar University

Status

Completed

Conditions

Cycloplegia

Treatments

Drug: Cycloplegics

Study type

Interventional

Funder types

Other

Identifiers

NCT05585736
Cycloplegia

Details and patient eligibility

About

Myopia is a public health problem, affecting the general population worldwide. The common modalities for correcting myopia include spectacles, contact lenses, and surgical procedures. Cycloplegic refraction is considered the gold standard for measuring refractive errors, especially in children. It has been well-established that generally myopia could be overestimated and hyperopia be underestimated if refraction was performed without cycloplegia.

Enrollment

388 patients

Sex

All

Ages

2 to 10 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Myopia or Hyperopia or compound myopic astigmatism.
  • Normal intra ocular pressure (IOP≤21 mmHg.
  • Age > 2 years and < 10 years

Exclusion criteria

  • Unwilling to participate in the study.
  • Previous ocular surgery
  • Any diagnosed ocular disease
  • History of ocular trauma
  • Irregular astigmatism on corneal topography.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

388 participants in 1 patient group

Cycloplegic refraction
Other group
Description:
All refractions were measured before and after cycloplegic addition to the eye.
Treatment:
Drug: Cycloplegics

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems